Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(12):961-962; doi:10.1093/jnci/92.12.961
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 12, 961-962, June 21, 2000
© 2000 Oxford University Press

NEWS

High-Dose Chemo For Breast Cancer: Does It Still Have a Chance?

Caroline McNeil

A year after the appearance of negative data on high-dose chemotherapy with bone marrow transplant for breast cancer, patients and physicians seem to be eschewing high-dose regimens with the same fervor they once pursued them. Accrual to ongoing transplant trials has slowed dramatically, and there are reports that its use outside of trials has dropped as well.

But such extreme pessimism is not warranted, according to breast cancer experts at the May meeting of the American Society of Clinical Oncology in New Orleans. Many believe that the pendulum has now . . . [Full Text of this Article]

No Answers Yet

Promising Results


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?